ORGN Earnings

ORGN reported its earnings on 2025-11-13, showcasing a revenue of 4.66M against an estimate of , resulting in a 0% surprise. The EPS was -0.11, surpassing the expected 0 by 0%. The stock experienced a -4.21% price change on the earnings day and a -8.18% change over the next five days, reflecting market reactions to the results.

Following ORGN's earnings announcement on 2025-11-13, the stock price moved by -4.21% on the day of the release. Over the subsequent five days, it saw a -8.18% change. Historically, ORGN's stock price tends to shift by an average of -1.19% in the 10 days leading up to earnings and -12.24% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate ORGN's annual revenue to reach 29.10M, while the EPS is projected at -0.07. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates revised downward by -71.52% over the past three months, indicating analyst expectation in the company's performance.

The correlation between ORGN's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved revised downward by -71.52%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ORGN's stock price typically moves by -1.19% in the 10 days before its earnings and -12.24% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of -0.07 and revenue of 29.10M.

The earnings call highlighted several negative factors, including delays in achieving EBITDA breakeven, significant impairment expenses, and lack of clear revenue guidance. The Q&A section revealed management's avoidance of direct answers about strategic reviews and market acceptance challenges. These issues, combined with the decision to cease investments in the furanics platform and delays in commercialization, suggest a negative sentiment and potential stock price decline in the short term.